No title
More than 400 million people in the world have type 2 diabetes, making it one of the most common diseases internationally according to the World Health Organization. Thiazolidinediones (TZDs) is used to treat type 2 diabetes since it increases the sensitivity of insulin in peripheral tissues. The knowledge about the mechanism how TZD works is limited which has resulted in patients getting serious
